UC College of Nursing researcher accepted for prestigious fellowship for nurse leaders and innovators

Samantha Boch, PhD, RN, assistant professor at the University of Cincinnati College of Nursing and affiliate faculty of the James M. Anderson Center for Health Systems Excellence at Cincinnati Children's Hospital is one of 16 nurse scientists accepted to the fifth cohort of the Betty Irene Moore Fellowship for Nurse Leaders and Innovators. The fellowship program, funded by grants from the Gordon and Betty Moore Foundation, recognizes and advances early-to-mid-career nursing scholars and innovators with a high potential to accelerate leadership in nursing research, practice, education, policy and entrepreneurship.

The Gordon and Betty Moore Foundation seeks to prepare nurses as collaborative leaders with the skills and confidence to inspire others, enact change and challenge the status quo. Through the creation of the Betty Irene Moore Fellowship for Nurse Leaders and Innovators, the foundation supports nurse leaders who take ideas to scale that advance high-quality, high-value care and optimal health outcomes.

“Our motto is UC Nurses. We See Leaders,” Interim Dean Gordon Gillespie, PhD, DNP, RN, FAAN, says. “Sam is the epitome of a nursing leader and scholar; I can’t wait to see the impact her project will have in advancing health equity and education in our country.”

Dr. Samantha Boch headshot

Samantha Boch, PhD, RN

As a part of the three-year fellowship program, Boch will receive $450,000 to conduct an innovative project focused on better understanding the health of and use of health services by children in foster care who also experience parental incarceration. Mentored by Cincinnati Children’s Hospital CHECK (Comprehensive Health Evaluations for Cincinnati’s Kids) Foster Care Center Medical Director Mary Greiner, MD, MS, and Scientific Director for Child Welfare Research Sarah Beal, PhD, Boch will leverage CHECK’s data to identify opportunities to better care for those children.

She will also partner with Ebony Underwood, CEO & Founder of WE GOT US NOW, the nation’s leading organization advancing the wellbeing of children and young adults with incarcerated parents, to co-design care guidelines for children who experience parental incarceration.

"I am thrilled to be in partnership with Sam,” Underwood says. “Her commitment to uplifting and elevating the subject matter expertise of those closest to this issue is a testament to her leadership and dedication in advancing the health equity and well-being for the vulnerable population of children impacted by parental incarceration."

A forensic nurse scientist, Boch’s program of research centers on the social determinants of health with particular emphasis on understanding and mitigating the consequences of mass incarceration on child and family health.

“I’m deeply honored to have been chosen as part of the cohort for the Betty Irene Moore Fellowship for Nurse Leaders and Innovators,” says Boch. “This is a unique opportunity to further develop my leadership skills and partner with amazing organizations, mentors, and individuals with lived experiences of parental incarceration to positively impact care and the health of these families.”

Featured top image of the UC College of Nursing. Photo provided.

Related Stories

1873 Results
1

UC College of Nursing researcher accepted for prestigious fellowship for nurse leaders and innovators

May 29, 2024

Samantha Boch, PhD, RN, assistant professor at the University of Cincinnati College of Nursing and affiliate faculty of the James M. Anderson Center for Health Systems Excellence at Cincinnati Children's Hospital is one of 16 nurse scientists accepted to the fifth cohort of the Betty Irene Moore Fellowship for Nurse Leaders and Innovators. The fellowship program, funded by grants from the Gordon and Betty Moore Foundation, recognizes and advances early-to-mid-career nursing scholars and innovators with a high potential to accelerate leadership in nursing research, practice, education, policy and entrepreneurship

4

UC faculty, grads win prestigious international research prize

August 30, 2022

A University of Cincinnati engineering professor and five of his students will receive a prestigious international award for their work studying ways to address water pollution. The Prince Sultan Bin Abdulaziz International Prize for Water will be awarded to UC College of Engineering and Applied Science distinguished research professor Dionysios Dionysiou and his student research team.

5

UC research examines COVID-19 vaccine hesitancy

August 25, 2022

One of the major roadblocks in the fight against the spread of COVID-19 in the early days of the pandemic was people refusing to get vaccinated against the virus. New research at UC examines that vaccine hesitancy and provides key insights into the behaviors and perceptions of the U.S. population during a critical time of the COVID-19 pandemic, just as vaccines were becoming more available.

7

UC launches Cincy BEARCAT study

September 16, 2022

The Cincy BEARCAT study aims to learn more about the causes of cardiac arrest. The just-launched study will create a biorepository of blood samples that can be used in this project as well as future research. The hypothesis is that there is a lot of diversity in cardiac arrest patients as far as the cause of the cardiac arrest.

8

UC research examines barriers to treatment of COVID-19 in local Latinx families

August 18, 2022

New research from the University of Cincinnati,examines the barriers as well as those that are helpful in the prevention and treatment of COVID-19 in Latinx families in Cincinnati. Researchers identified primary barriers that include insecurities in food, jobs and housing and immigration. Key facilitators included having trusted messengers of health-related information.

10

UC research could change vaccine practices

October 20, 2022

New research out of the University of Cincinnati shows that a course of a hepatitis B vaccine provides complete protection for people with HIV. The UC research shows that a three-dose course of the hepatitis B vaccine HEPLISAV-B provides complete protection for people living with HIV who have never been vaccinated against or exposed to the hepatitis B virus (HBV).